GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
H

Hubei Zhenhua Chemical Co 603067.SS · CNY

Materials · Shanghai · 🇨🇳 China

Compare

22.09

-3.11%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CNY, from our data supplier.

FY2025

Revenue

CN¥4.54bn

FY2016FY2025

Net income

CN¥659.0m

FY2016FY2025

Free cash flow

−CN¥81.0m

FY2016FY2025

Shareholders' equity

CN¥3.73bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueCN¥4.54bnCN¥4.07bnCN¥3.70bnCN¥3.53bnCN¥2.99bnCN¥1.28bnCN¥1.42bnCN¥1.40bnCN¥1.19bnCN¥874.5m
Gross profitCN¥1.47bnCN¥1.01bnCN¥896.3mCN¥945.6mCN¥740.8mCN¥378.7mCN¥397.1mCN¥400.2mCN¥288.2mCN¥254.3m
Research and developmentCN¥147.3mCN¥128.3mCN¥114.6mCN¥106.3mCN¥82.7mCN¥43.0mCN¥49.8mCN¥50.9mCN¥38.7mCN¥27.1m
Operating incomeCN¥784.3mCN¥548.2mCN¥429.7mCN¥487.8mCN¥349.2mCN¥171.8mCN¥157.3mCN¥170.2mCN¥111.0mCN¥96.8m
Net incomeCN¥659.0mCN¥472.9mCN¥370.8mCN¥417.0mCN¥310.7mCN¥149.8mCN¥136.3mCN¥146.2mCN¥100.1mCN¥79.7m
Diluted earnings per share1.240.900.700.800.640.360.330.330.250.24

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsCN¥6.12bnCN¥5.06bnCN¥4.25bnCN¥3.98bnCN¥3.53bnCN¥2.01bnCN¥1.48bnCN¥1.35bnCN¥1.23bnCN¥1.15bn
Cash and short-term investments—CN¥485.9mCN¥271.1mCN¥310.5mCN¥193.9mCN¥442.6mCN¥319.2mCN¥172.9mCN¥74.7mCN¥45.4m
Total liabilitiesCN¥2.38bnCN¥1.85bnCN¥1.38bnCN¥1.42bnCN¥1.36bnCN¥554.8mCN¥144.2mCN¥113.1mCN¥106.9mCN¥102.6m
DebtCN¥702.3mCN¥1.11bnCN¥765.9mCN¥890.4mCN¥845.5mCN¥352.9mCN¥11.8m——CN¥20.4m
Shareholders' equityCN¥3.73bnCN¥3.16bnCN¥2.81bnCN¥2.52bnCN¥2.16bnCN¥1.44bnCN¥1.34bnCN¥1.24bnCN¥1.12bnCN¥1.04bn
Shares outstanding534m524m527m521m488m412m419m445m394m333m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsCN¥329.5mCN¥333.4mCN¥396.3mCN¥491.0mCN¥407.9mCN¥6.5mCN¥200.9mCN¥81.4m−CN¥16.9mCN¥107.9m
Capital spending−CN¥410.5m−CN¥284.3m−CN¥292.7m−CN¥260.3m−CN¥329.7m−CN¥106.0m−CN¥24.9m−CN¥10.9m−CN¥11.0m−CN¥59.4m
Free cash flow−CN¥81.0mCN¥49.1mCN¥103.7mCN¥230.7mCN¥78.3m−CN¥99.4mCN¥176.0mCN¥70.4m−CN¥27.8mCN¥48.5m
Dividends paid−CN¥120.7m−CN¥120.5m−CN¥136.9m−CN¥93.5m−CN¥45.9m−CN¥43.1m−CN¥37.0m−CN¥31.5m−CN¥27.8m−CN¥10.1m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueCN¥1.61bnCN¥1.19bnCN¥1.32bnCN¥1.03bnCN¥1.17bnCN¥1.02bnCN¥1.07bnCN¥1.01bn
Gross profitCN¥384.4mCN¥319.6mCN¥319.7mCN¥270.4mCN¥358.1mCN¥269.3mCN¥249.7mCN¥258.7m
Operating incomeCN¥218.5mCN¥166.6mCN¥196.5mCN¥136.2mCN¥210.3mCN¥135.6mCN¥127.8mCN¥147.5m
Net incomeCN¥186.6mCN¥121.6mCN¥249.5mCN¥111.6mCN¥180.6mCN¥117.4mCN¥109.0mCN¥122.9m
Diluted earnings per share0.350.230.470.210.340.220.210.23
Cash from operations———CN¥28.0mCN¥13.0m−CN¥6.0mCN¥175.0mCN¥31.0m
Capital spending−CN¥62.0m−CN¥45.0m−CN¥253.0m−CN¥22.0m−CN¥84.0m−CN¥49.0m−CN¥62.0m−CN¥94.0m
Free cash flow———CN¥6.0m−CN¥71.0m−CN¥55.0mCN¥113.0m−CN¥63.0m
Total assetsCN¥6.95bnCN¥6.50bnCN¥6.12bnCN¥5.43bnCN¥5.21bnCN¥5.17bnCN¥5.06bnCN¥4.88bn
Cash and short-term investments———CN¥300.2mCN¥239.7mCN¥472.2mCN¥485.9mCN¥435.0m
DebtCN¥485.1mCN¥754.4mCN¥702.3mCN¥614.3mCN¥819.4mCN¥1.13bnCN¥1.11bnCN¥1.36bn
Shareholders' equityCN¥4.33bnCN¥3.85bnCN¥3.73bnCN¥3.47bnCN¥3.36bnCN¥3.28bnCN¥3.16bnCN¥3.05bn

Financial ratios

Data as of 24 Sept 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin32.3%24.9%24.2%26.8%24.7%29.6%
Operating margin17.3%13.5%11.6%13.8%11.7%13.4%
Net margin14.5%11.6%10.0%11.8%10.4%11.7%
Return on equity17.7%15.0%13.2%16.6%14.4%10.4%
Return on assets10.8%9.4%8.7%10.5%8.8%7.5%
Free cash flow yield3.4%2.9%3.2%3.5%3.7%0.7%
Revenue growth11.5%9.9%4.7%18.1%134.1%-10.0%
Earnings growth39.4%27.5%-11.1%34.2%107.3%9.9%
Current ratio1.90x2.96x2.79x1.82x1.94x6.99x
Debt to equity0.19x0.35x0.27x0.20x0.39x0.24x
Equity ratio60.9%62.5%66.0%63.2%61.1%72.0%
Interest coverage18.38x14.49x12.18x13.85x9.07x41.18x
R&D as a share of sales3.2%3.2%3.1%3.0%2.8%3.4%
Buybacks as a share of market value-1.9%0.6%-1.2%-6.8%-18.3%1.8%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue8.7%28.8%19.3%
Operating income17.1%35.5%27.3%
Net income16.5%34.5%26.6%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin28.8%27.3%27.1%27.1%
Operating margin15.5%14.2%13.8%13.1%
Net margin13.2%12.1%11.8%11.3%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings23.310.010.311.412.412.913.311.919.443.2
Price to sales3.41.21.01.41.31.51.31.21.63.9

Dividends and splits

Per share, in the currency the company pays

Paid for 9 years. Last went ex-dividend on 15 Jul 2026.

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Paid in the year0.160.1360.1310.1480.1310.0660.0710.061
  • 1-to-1 reverse split · 24 Jun 2025
  • 7-for-5 split · 21 May 2019
  • 7-for-5 split · 8 May 2018

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.